Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Edelman

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|August 29, 2003
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE studyLars H Lindholm, Björn Dahlöf, Jonathan M Edelman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 8, 2003
Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover studyDon A Bukstein, Donna L Bratton, Kelly M Firriolo, et al.
American Journal of Hypertension|April 17, 2010
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patientsPeter M Okin, Darcy A Hille, Sverre E Kjeldsen, et al.
Annals of Internal Medicine|September 6, 2007
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patientsPeter M Okin, Richard B Devereux, Katherine E Harris, et al.
The Journal of Allergy and Clinical Immunology|December 5, 2002
Effects of montelukast and beclomethasone on airway function and asthma controlElliot Israel, Paul S Chervinsky, Bruce Friedman, et al.
European Journal of Heart Failure|January 18, 2011
Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE studyPeter M Okin, Lasse Oikarinen, Matti Viitasalo, et al.
The American Journal of Medicine|June 1, 2005
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trialRobert S Zeiger, Steven R Bird, Michael S Kaplan, et al.
Circulation|April 1, 2009
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)Peter M Okin, Lasse Oikarinen, Matti Viitasalo, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patientsFrank S Rhame, Sandy L Rawlins, Richard A Petruschke, et al.
Circulation|August 25, 2004
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trialRichard B Devereux, Björn Dahlöf, Eva Gerdts, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|August 29, 2003
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE studyLars H Lindholm, Björn Dahlöf, Jonathan M Edelman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 8, 2003
Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover studyDon A Bukstein, Donna L Bratton, Kelly M Firriolo, et al.
American Journal of Hypertension|April 17, 2010
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patientsPeter M Okin, Darcy A Hille, Sverre E Kjeldsen, et al.
Annals of Internal Medicine|September 6, 2007
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patientsPeter M Okin, Richard B Devereux, Katherine E Harris, et al.
The Journal of Allergy and Clinical Immunology|December 5, 2002
Effects of montelukast and beclomethasone on airway function and asthma controlElliot Israel, Paul S Chervinsky, Bruce Friedman, et al.
European Journal of Heart Failure|January 18, 2011
Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE studyPeter M Okin, Lasse Oikarinen, Matti Viitasalo, et al.
The American Journal of Medicine|June 1, 2005
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trialRobert S Zeiger, Steven R Bird, Michael S Kaplan, et al.
Circulation|April 1, 2009
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)Peter M Okin, Lasse Oikarinen, Matti Viitasalo, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patientsFrank S Rhame, Sandy L Rawlins, Richard A Petruschke, et al.
Circulation|August 25, 2004
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trialRichard B Devereux, Björn Dahlöf, Eva Gerdts, et al.
Pageof 5